ShouTi follows October debut by hiring Credit Suisse’s Ding as CFO
Plus: C4X, IMV and Neuvogen
ShouTi Inc. hired former Credit Suisse banker Ding Ding as CFO. Ding was Credit Suisse’s head of APAC healthcare investment banking and capital markets. ShouTi, which has offices in Shanghai and South San Francisco, emerged from stealth in October with a crossover $100 million series B round and a platform to develop oral small molecules to replace GPCR-targeting biologics and peptides for chronic cardiovascular, metabolic and pulmonary diseases. The company’s lead program is in Phase I testing for pulmonary arterial hypertension. Investors in the series B included BVF, Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures.
Drug discovery company C4X Discovery Holdings plc (LSE:C4XD) hired Catherine Tralau-Stewart as CSO, effective Jan. 4. Tralau-Stewart joins C4X from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), where she was a senior director of alliances. ...